Put Options

5 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2019

May 14, 2019

SELL
$17.59 - $31.05 $605,096 - $1.07 Million
-34,400 Closed
0 $0
Q4 2018

Feb 11, 2021

BUY
$18.97 - $31.47 $646,042 - $1.07 Million
34,056 Added 9900.0%
34,400 $899,000
Q4 2018

Feb 14, 2019

BUY
$18.97 - $31.47 $6,525 - $10,825
344 New
344 $22,000
Q1 2018

May 14, 2018

SELL
$14.05 - $20.2 $4.22 Million - $6.06 Million
-300,000 Closed
0 $0
Q4 2017

Feb 11, 2021

BUY
$12.85 - $18.1 $3.86 Million - $5.43 Million
300,000
300,000 $4.56 Million

Others Institutions Holding VNDA

About Vanda Pharmaceuticals Inc.


  • Ticker VNDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,561,500
  • Market Cap $264M
  • Description
  • Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...
More about VNDA
Track This Portfolio

Track Pura Vida Investments, LLC Portfolio

Follow Pura Vida Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pura Vida Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pura Vida Investments, LLC with notifications on news.